Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis
A lab-made peptide known in research as LY3437943, developed by Eli Lilly and now in Phase 3 human trials
Puri P, Dhiman RK, Taneja S et al (2021) Nutrition in chronic liver disease: consensus statement of the Indian National Association for Study of the Liver
Goto T et al
Ingredients: Deionized Water, Niacinamide, Aloe Barbadensis Leaf Juice, Chamomilla Recutita (Matricaria) Flower Extract, Melaleuca Alternifolia (Tea Tree) Leaf Oil, Lactobacillus/Ganoderma Lucidum (Reishi Mushroom) Extract / Lentinus Edodes (Shiitake Mushroom) Extract Ferment Filtrate, Glycerin, Royal Jelly, Copper Tripeptide-1, Lactococcus Ferment Lysate, Saccharomyces/Capsicum Annuum Fruit Ferment Filtrate, Lactobacillus Ferment Lysate, Hydrolyzed Ganoderma Lucidum Mushroom Extract, Sodium Hyaluronate, Beta-Glucan, Centella Asiatica Extract, Fructooligosaccharides, Beta Vulgaris Beet Root Extract, Acetyl Hexapeptide-8, Palmitoyl Tripeptide-5, Silver Dihydrogen Citrate, Citric Acid